NEW YORK & MAINZ, Germany–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the U.S.
The main content of preclinical toxicology research is the safety evaluation of drugs. Whether the drug is safe and effective is the determining factor for
Antibody-drug conjugates (ADCs) are the coupling of cytotoxic small-molecule drugs to targeted monoclonal antibodies through ADC linkers, which can reduce the toxicity of small-molecule drugs
Cytotoxicity is a key factor determining the lethality of ADC drugs. An ideal cytotoxin should have the following properties: Highly toxic: Usually moderately toxic cytotoxic
With the continuous increase in R&D investment of global pharmaceutical companies, the competition in the global pharmaceutical market has become increasingly fierce. Enterprises are increasing
You may have heard of “targeted therapy” for tumors, and perhaps in your impression, it represents “new medicine, advanced, expensive”. Compared with chemotherapy, what are
On August 19, Axsome Therapeutics announced that the US FDA approved Auvelity (dextromethorphan 45mg + bupropion 105mg) compound sustained-release tablets for the treatment of adult
Almost all major forms of diabetes are caused by insufficient amounts of beta cells (the cells in the pancreas that produce and distribute insulin). When
On August 17, Atomwise announced that it has entered into a strategic and exclusive research collaboration with Sanofi to leverage its AtomNet® platform for computational
Immunotherapy, a targeted approach to the treatment of malignant tumors, has shown great potential by using the autoimmune system to fight tumor cells. Immunotherapy includes
On August 15, the UK Medicines and Health Products Administration (MHRA) approved the bivalent vaccine mRNA-1273.214 produced by Moderna against both the Omicron variant BA.1
PARIS, August 17, 2022. Sanofi is discontinuing the global clinical development program of amcenestrant, an investigational oral selective estrogen receptor degrader (SERD). The decision is
